4 minute read
Apr. 19, 2022

INE963: An Oral, Single Dose, Fast-Acting Antimalarial

INE963

oral blood stage antimalarial in Ph. I (healthy volunteers) from 1.5M cmpd phenotypic screen + opt. J. Med. Chem., March 1, 2022 Novartis (NIBR), Emeryville, CA

twitterlinkedinprintemail